Pfizer’s Talzenna in combi with Xtandi improves survival outcomes in metastatic castration resistant prostate cancer: New York Saturday, February 15, 2025, 11:00 Hrs [IST] Pfize ...
A NEW scheme has been launched to boost the research careers of healthcare professionals. The National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre (BRC) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback